Patents Assigned to Cellerix, S.L.
  • USE OF ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS IN TREATING FISTULA
    Publication number: 20100098669
    Abstract: Provided herein are novel methods and compositions utilizing adipose tissue-derived stromal stem cells for treating fistulae.
    Type: Application
    Filed: May 16, 2006
    Publication date: April 22, 2010
    Applicants: Cellerix, S.L., Universidad Autonoma de Madrid
    Inventors: Maria Gema Fernández Miguel, Manuel Angel González de la Peña, Rosa Ana Garcia Castro, Mariano Garcia Arranz, Damián Garcia Olmo
  • USE OF ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE
    Publication number: 20090148419
    Abstract: The present invention relates to the use of a particular type of adipose tissue derived mesenchymal stem cells (AD-MSCs), which exert immunosuppressive properties, in the manufacture of a pharmaceutical composition for the prevention and treatment of the graft-versus-host disease (GVHD) produced after allogeneic hematopoietic stem cell transplantation.
    Type: Application
    Filed: December 7, 2006
    Publication date: June 11, 2009
    Applicants: CELLERIX, S.L., CENTRO DE INVESTIGACIONES ENERGETICAS, MEDIOAMBIENTALES Y TECHNOLOGICAS
    Inventors: Manuel Angel Gonzalez De La Pena, Dirk Buscher, Aitor Beraza Perez, Juan Bueren Roncero, Rosa Maria Yanez Gonzalez, Maria Lamana Luzuriaga
  • Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue
    Publication number: 20060073124
    Abstract: Methods for the identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue. Specifically, this invention relates to an adult multipotent cell or a cell population or composition comprising said cell, isolated from non-osteochondral mesenchymal tissue, characterized in that the cell is positive for the following markers: CD9, CD10, CD13, CD29, CD44, CD49A, CD51, CD54, CD55, CD58, CD59, CD90 and CD105 and because it lacks expression of the following markers: CD11b, CD14, CD15, CD16, CD31, CD34, CD45, CD49f, CD102, CD104, CD106 and CD133.
    Type: Application
    Filed: February 25, 2005
    Publication date: April 6, 2006
    Applicant: Cellerix, S.L. Universidad Autonoma De Madrid
    Inventors: Rosa Garcia Castro, Manuel Gonzalez de la Pena, Gema Miguel, Mariano Arranz, Damian Olmo
  • Biomaterial for suturing
    Publication number: 20060047312
    Abstract: A biomaterial for suturing comprising a physiologically compatible support material coated with a cellular population with proliferative and/or differentiation capacity, characteristics which facilitate the regeneration of the sutured tissue. This biomaterial for suturing not only brings together the two edges of an open wound, but also contributes actively to the healing process, thereby accelerating the tissue repair process. Also disclosed are methods for making the biomaterial and methods for using the biomaterials in therapy.
    Type: Application
    Filed: February 14, 2005
    Publication date: March 2, 2006
    Applicant: Cellerix, S.L. Universidad
    Inventors: Damian Garcia Olmo, Gema Miguel, Manuel Gonzalez de la Pena
  • Use of adipose tissue-derived stromal stem cells in treating fistula
    Publication number: 20060045872
    Abstract: Provided herein are novel methods and compositions utilizing adipose tissue-derived stromal stem cells for treating fistulae.
    Type: Application
    Filed: June 24, 2005
    Publication date: March 2, 2006
    Applicants: Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco, Cellerix, S.L.
    Inventors: Maria Gema Miguel, Manuel De La Pena, Rosa Castro, Mariano Arranz, Damian Garcia-Olmo